Sio Capital Management, LLC Revance Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $2.18 Million - $4.37 Million	468,871 New	468,871 $2.31 Million
Q3 2023 Nov 14, 2023	BUY	$11.47 - $25.07 $2.31 Million - $5.04 Million	200,977 Added 142.03%	342,477 $3.93 Million
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $3.5 Million - $5.32 Million	141,500 New	141,500 $3.58 Million
Q1 2020 May 15, 2020	SELL	$12.46 - $27.81 $1.09 Million - $2.44 Million	-87,700 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$11.66 - $20.15 $2.54 Million - $4.39 Million	-217,964 Reduced 71.31%	87,700 $1.42 Million
Q3 2019 Nov 14, 2019	SELL	$10.22 - $14.5 $1 Million - $1.42 Million	-98,000 Reduced 24.28%	305,664 $3.97 Million
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $1.59 Million - $2.31 Million	149,083 Added 58.56%	403,664 $5.24 Million
Q1 2019 May 15, 2019	BUY	$15.4 - $20.39 $1.34 Million - $1.77 Million	86,857 Added 51.79%	254,581 $4.01 Million
Q4 2018 Feb 14, 2019	BUY	$18.06 - $24.96 $60,880 - $84,140	3,371 Added 2.05%	167,724 $3.38 Million
Q3 2018 Nov 14, 2018	BUY	$23.55 - $30.1 $1.49 Million - $1.9 Million	63,061 Added 62.26%	164,353 $4.08 Million
Q2 2018 Aug 14, 2018	BUY	$27.45 - $33.35 $2.78 Million - $3.38 Million	101,292 New	101,292 $2.78 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.